论文部分内容阅读
目的:探讨与研究阿奇霉素联合痰热清在治疗小儿肺炎中的临床疗效和价值。方法:将我院收治的小儿肺炎患儿纳入研究,随机分为观察组和对照组,对照组使用阿奇霉素治疗,观察组使用阿奇霉素联合痰热清治疗。观察比较两组临床治疗效果,治疗前后血清C反应蛋白和免疫球蛋白水平,平均住院时间及不良反应发生率。结果:观察组临床疗效明显高于对照组,差异有统计学意义,P<0.01;治疗前两组C反应蛋白及免疫球蛋白水平差异无统计学意义,治疗后两组均有所好转,观察组好转情况高于对照组,差异显著(P<0.05)观察组平均住院时间及不良反应发生情况少于对照组,差别均具有统计学意义(P<0.05)。结论:联合阿奇霉素和痰热清治疗小儿肺炎,可明显提高临床治疗效果,同时改善小儿血清C反应蛋白和免疫球蛋白水平,对临床治疗具有积极意义,值得推广。
Objective: To investigate and study the clinical efficacy and value of azithromycin combined with Tanreqing in the treatment of children with pneumonia. Methods: Children with pneumonia in our hospital were included in the study, were randomly divided into observation group and control group, the control group treated with azithromycin, the observation group with azithromycin combined with Tanreqing treatment. The clinical therapeutic effects were observed and compared between before and after treatment. Serum C-reactive protein and immunoglobulin levels, mean length of stay, and incidence of adverse reactions were observed. Results: The clinical efficacy of the observation group was significantly higher than that of the control group, the difference was statistically significant (P <0.01). There was no significant difference in C-reactive protein and immunoglobulin levels between the two groups before treatment, and both groups improved after treatment The improvement of the group was higher than that of the control group (P <0.05). The average length of hospital stay and adverse reactions in the observation group were less than those in the control group. The difference was statistically significant (P <0.05). Conclusion: The combination of azithromycin and Tanreqing treatment of children with pneumonia can significantly improve the clinical treatment effect, while improving serum C-reactive protein and immunoglobulin levels in children, has a positive clinical treatment, worth promoting.